Researchers at Shanghai Jiao Tong University have unveiled DynaTOF, an artificial intelligence framework designed to streamline the monitoring and postoperative care of children born with tetralogy of Fallot, one of the most prevalent cyanotic congenital heart defects. The findings were published in eBioMedicine in 2026. Echocardiography serves as the primary diagnostic and monitoring tool for the condition, yet interpreting dynamic ultrasound images and extracting precise cardiac measurements places a heavy burden on clinicians. Manual assessments often vary between practitioners and can be compromised by high workloads. DynaTOF addresses these challenges by integrating computer vision and quantitative analysis into a unified clinical decision-support system. The framework operates through a three-stage process. First, it automatically identifies standard echocardiographic views, ensuring the algorithm processes anatomically relevant footage. Second, it detects and measures critical cardiac diameters, reducing repetitive manual labor and standardizing metrics across institutions. Third, DynaTOF employs a multimodal architecture that fuses visual features from echocardiographic videos with extracted quantitative data. This approach mirrors clinical reasoning, where physicians synthesize multiple imaging cues rather than relying on isolated metrics. The system also utilizes preoperative imaging, surgical details, and follow-up scheduling to forecast postoperative recovery trajectories and stratify long-term complication risks. Validated using multi-center clinical data comprising healthy controls, conditions mimicking tetralogy of Fallot, and confirmed cases, DynaTOF demonstrated robust performance in diagnostic classification, recovery pattern prediction, and risk stratification. The model successfully distinguished complex congenital presentations from anatomically similar pathologies, highlighting its utility in real-world diagnostic scenarios where clinical ambiguity is common. By anticipating abnormal recovery scores and identifying patients requiring intensified monitoring, the framework enables medical teams to allocate resources more efficiently and tailor follow-up protocols. Researchers emphasize that DynaTOF is engineered to augment, not replace, clinical expertise. The algorithm outputs probabilistic recovery patterns rather than definitive prognoses, preserving physician oversight while reducing interpretive variability. Lead developer Yingshuang Gao notes that the system was explicitly designed to align with the entire clinical pathway, bridging diagnosis, surgical planning, and longitudinal care rather than functioning as an isolated technical module. Despite promising results, the development team acknowledges that broader clinical validation remains necessary. Variations in ultrasound hardware, institutional workflows, and demographic factors could influence algorithmic performance across diverse healthcare settings. Continuous real-world testing will be required to ensure reliability before widespread deployment. Nevertheless, the project marks a significant step toward embedding predictive, workflow-integrated AI into pediatric cardiology. By automating routine assessments and highlighting subtle clinical patterns, DynaTOF aims to reduce administrative and interpretive friction, allowing clinicians to dedicate more time to direct patient and family care. The initiative underscores a growing consensus in medical technology that effective AI must be structurally aligned with established clinical pathways rather than optimized for narrow computational tasks alone.